文献速递肿瘤 PET/CT

头颈鳞癌代谢与遗传异质性关联及预后意义:FDG PET与基因组整合分析

Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis.
PubMed 文献 · EJNMMI Res · 2019-11-21

本研究基于TCGA头颈鳞癌数据集,评估遗传异质性(MATH)与代谢异质性(FDG PET特征)的关联及预后价值。结果显示二者呈轻度关联,均能预测生存,联合应用可改善预后分层,且MATH与糖酵解特征(GlycoS)为独立预后因素。

要点

  • FDG PET代谢异质性与MATH呈轻度关联(ρ=0.4~0.5,P<0.05)。
  • MATH与代谢异质性联合较单用MATH预后分层更优。
  • MATH和GlycoS均为独立预后因素,可精准预后。

核心结论

  • FDG PET评估的代谢异质性和代谢体积特征与头颈鳞癌遗传异质性呈轻度关联。
  • 代谢与遗传异质性特征均能预测生存,联合应用具有附加预后价值。
  • MATH和GlycoS是头颈鳞癌的独立预后因素,经验证后可用于精准预后。

研究设计与样本

  • 从TCGA头颈鳞癌数据集获取MATH评分(n=508)和肿瘤糖酵解特征GlycoS(n=503)。
  • 从TCIA识别匹配的33例接受18F-FDG PET检查的患者,提取原发肿瘤代谢、代谢体积和代谢异质性特征。
  • 评估遗传与代谢特征的关联及其预后价值。

主要发现

  • 肿瘤代谢异质性和代谢体积特征与MATH呈轻度关联(n=25,ρ=0.4~0.5,所有特征P<0.05)。
  • FDG PET特征和MATH较高的患者死亡更早。
  • MATH与肿瘤代谢异质性特征联合较MATH预后分层更优。
  • 较高的MATH和GlycoS与显著更差的总生存相关(n=499,MATH P=0.002,GlycoS P=0.0001)。
  • 调整临床病理特征及彼此后,MATH和GlycoS均独立预测总生存(P=0.015和0.006)。

临床怎么用

  • FDG PET代谢异质性特征可与遗传异质性(MATH)联合用于头颈鳞癌预后分层。
  • MATH和GlycoS可作为独立预后因素,经验证后用于精准预后评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The linkage between the genetic and phenotypic heterogeneity of the tumor has not been thoroughly evaluated. Herein, we investigated how the genetic and metabolic heterogeneity features of the tumor are associated with each other in head and neck squamous cell carcinoma (HNSC). We further assessed the prognostic significance of those features. METHODS: The mutant-allele tumor heterogeneity (MATH) score (n = 508), a genetic heterogeneity feature, and tumor glycolysis feature (GlycoS) (n = 503) were obtained from the HNSC dataset in the cancer genome atlas (TCGA). We identified matching patients (n = 33) who underwent 18F-fluorodeoxyglucose positron emission tomography (FDG PET) from the cancer imaging archive (TCIA) and obtained the following information from the primary tumor: metabolic, metabolic-volumetric, and metabolic heterogeneity features. The association between the genetic and metabolic features and their prognostic values were assessed. RESULTS: Tumor metabolic heterogeneity and metabolic-volumetric features showed a mild degree of association with MATH (n = 25, ρ = 0.4~0.5, P < 0.05 for all features). The patients with higher FDG PET features and MATH died sooner. Combination of MATH and tumor metabolic heterogeneity features showed a better stratification of prognosis than MATH. Also, higher MATH and GlycoS were associated with significantly worse overall survival (n = 499, P = 0.002 and 0.0001 for MATH and GlycoS, respectively). Furthermore, both MATH and GlycoS independently predicted overall survival after adjusting for clinicopathologic features and the other (P = 0.015 and 0.006, respectively). CONCLUSION: Both tumor metabolic heterogeneity and metabolic-volumetric features assessed by FDG PET showed a mild degree of association with genetic heterogeneity in HNSC. Both metabolic and genetic heterogeneity features were predictive of survival and there was an additive prognostic value when the metabolic and genetic heterogeneity features were combined. Also, MATH and GlycoS were independent prognostic factors in HNSC; they can be used for precise prognostication once validated.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Choi J, Gim JA, Oh C, et al. Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis. EJNMMI Res. 2019. PMID: 31754877. doi:10.1186/s13550-019-0563-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。